RXRX logo

RXRX
Recursion Pharmaceuticals Inc

14,389
Mkt Cap
$2.48B
Volume
8.14M
52W High
$12.36
52W Low
$3.79
PE Ratio
-2.64
RXRX Fundamentals
Price
$4.64
Prev Close
$4.77
Open
$4.73
50D MA
$5.13
Beta
2.65
Avg. Volume
31.12M
EPS (Annual)
-$1.69
P/B
2.24
Loading...
Loading...
News
all
press releases
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Platform Technologies Drive $211B Surge in Precision Cancer Treatment Platform Technologies Drive $211B Surge in Precision Cancer Treatment PR Newswire VANCOUVER, BC, Dec. 11, 2025 Issued on behalf...
PR Newswire·4h ago
News Placeholder
More News
News Placeholder
Norges Bank Buys Shares of 3,169,938 Recursion Pharmaceuticals, Inc. $RXRX
Norges Bank purchased a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Norges Bank Buys Shares of 3,169,938 Recursion Pharmaceuticals, Inc. $RXRX
Norges Bank purchased a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Norges Bank Buys Shares of 3,169,938 Recursion Pharmaceuticals, Inc. $RXRX
Norges Bank purchased a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up - Time to Buy?
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Up - Time to Buy...
MarketBeat·3d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue?
Recursion Pharmaceuticals (RXRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·6d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue?
Recursion Pharmaceuticals (RXRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·6d ago
News Placeholder
Insider Selling: Recursion Pharmaceuticals (NASDAQ:RXRX) Director Sells 220,000 Shares of Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) Director Blake Borgeson sold 220,000 shares of the company's stock in a transaction dated Tuesday, December 2nd. The stock was sold at...
MarketBeat·6d ago
News Placeholder
Lightning Round: Recursion Pharmaceuticals and NuScale Power
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power...
CNBC Television-YouTube·7d ago
News Placeholder
Cramer's Lightning Round: Recursion Pharmaceuticals 'has been horrendous'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...
CNBC: Mad Money with Jim Cramer·7d ago

Latest RXRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.